Jerome P. Richie

18.4k total citations · 3 hit papers
273 papers, 13.3k citations indexed

About

Jerome P. Richie is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jerome P. Richie has authored 273 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Surgery, 134 papers in Pulmonary and Respiratory Medicine and 66 papers in Molecular Biology. Recurrent topics in Jerome P. Richie's work include Testicular diseases and treatments (84 papers), Prostate Cancer Treatment and Research (83 papers) and Prostate Cancer Diagnosis and Treatment (76 papers). Jerome P. Richie is often cited by papers focused on Testicular diseases and treatments (84 papers), Prostate Cancer Treatment and Research (83 papers) and Prostate Cancer Diagnosis and Treatment (76 papers). Jerome P. Richie collaborates with scholars based in United States, Netherlands and Germany. Jerome P. Richie's co-authors include Philip W. Kantoff, Andrew A. Renshaw, Anthony V. D’Amico, Omid C. Farokhzad, Róbert Langer, Marc B. Garnick, Donald G. Skinner, Sangyong Jon, Benjamin A. Teply and Jianjun Cheng and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Jerome P. Richie

259 papers receiving 12.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression correlates of clinical prostate cancer behavior

2002 1.8k citations Andrew A. Renshaw, Anthony V. D’Amico et al. profile →
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

2006 1.4k citations Omid C. Farokhzad, Jianjun Cheng et al. Proceedings of the National Academy of Sciences profile →
Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

1998 860 citations Robert C. Flanigan, Jerome P. Richie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerome P. Richie United States	54	6.4k	4.3k	3.4k	1.7k	1.5k	273	13.3k
Andrew C. von Eschenbach United States	61	7.7k 1.2×	3.3k 0.8×	2.7k 0.8×	1.5k 0.9×	3.8k 2.6×	202	13.9k
Lawrence D. True United States	61	8.0k 1.2×	6.1k 1.4×	2.0k 0.6×	1.2k 0.7×	3.5k 2.4×	277	15.9k
Harm van Tinteren Netherlands	69	5.7k 0.9×	3.0k 0.7×	6.1k 1.8×	943 0.6×	5.2k 3.5×	340	17.1k
Malcolm D. Mason United Kingdom	64	7.5k 1.2×	6.5k 1.5×	3.2k 0.9×	1.3k 0.8×	3.7k 2.5×	241	18.0k
William R. Fair United States	75	7.2k 1.1×	4.1k 0.9×	7.3k 2.1×	1.9k 1.1×	3.1k 2.1×	315	17.9k
Paul F. Schellhammer United States	53	9.5k 1.5×	3.3k 0.8×	4.0k 1.2×	1.5k 0.9×	5.0k 3.3×	274	17.6k
Leonard G. Gomella United States	63	6.7k 1.0×	3.4k 0.8×	2.6k 0.8×	1.1k 0.6×	2.5k 1.7×	385	12.7k
Henk G. van der Poel Netherlands	54	7.6k 1.2×	1.3k 0.3×	4.4k 1.3×	2.7k 1.6×	2.1k 1.4×	412	13.2k
Theodore L. DeWeese United States	53	4.1k 0.6×	3.1k 0.7×	1.1k 0.3×	411 0.2×	2.7k 1.8×	226	10.0k
Joseph L. Chin Canada	51	6.9k 1.1×	1.5k 0.4×	2.9k 0.8×	1.4k 0.8×	2.2k 1.5×	340	11.1k

Countries citing papers authored by Jerome P. Richie

Since Specialization

Citations

This map shows the geographic impact of Jerome P. Richie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome P. Richie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome P. Richie more than expected).

Fields of papers citing papers by Jerome P. Richie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome P. Richie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome P. Richie. The network helps show where Jerome P. Richie may publish in the future.

Co-authorship network of co-authors of Jerome P. Richie

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome P. Richie. A scholar is included among the top collaborators of Jerome P. Richie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome P. Richie. Jerome P. Richie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prasad, Sandip M., Alexander Berry, Stuart R. Lipsitz, et al.. (2009). Surgical Apgar Outcome Score: Perioperative Risk Assessment for Radical Cystectomy. The Journal of Urology. 181(3). 1046–1053. 75 indexed citations

Prasad, Sandip M., Nancy L. Keating, Qin Wang, et al.. (2008). Variations in Surgeon Volume and Use of Pelvic Lymph Node Dissection with Open and Minimally Invasive Radical Prostatectomy. Urology. 72(3). 647–652. 32 indexed citations

Farokhzad, Omid C., Jianjun Cheng, Benjamin A. Teply, et al.. (2006). Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proceedings of the National Academy of Sciences. 103(16). 6315–6320. 1353 indexed citations breakdown →

Richie, Jerome P.. (2005). Open retroperitoneal lymph node dissection.. PubMed. 12 Suppl 1. 37–9. 4 indexed citations

Richie, Jerome P.. (2005). Radical prostatectomy vs watchful waiting in early prostate cancer. British Journal of Urology. 96(7). 951–952. 20 indexed citations

Ferdinand, Angeline, et al.. (2005). Chromatofocusing fractionation and two‐dimensional difference gel electrophoresis for low abundance serum proteins. PROTEOMICS. 5(12). 3183–3192. 39 indexed citations

D’Amico, Anthony V., Ming‐Hui Chen, Andrew A. Renshaw, et al.. (2002). Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. International Journal of Radiation Oncology*Biology*Physics. 54(2). 436–441. 28 indexed citations

Linson, Patrick W., Andrew K. Lee, Ming‐Hui Chen, et al.. (2002). Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?. Urology. 59(5). 704–708. 25 indexed citations

Kumar, Sanjaya, et al.. (1999). SHORT AND LONG-TERM MORBIDITY OF THORACOABDOMINAL INCISION FOR NEPHRECTOMY: A COMPARISON WITH THE FLANK APPROACH. The Journal of Urology. 162(6). 1927–1929. 11 indexed citations

10.

Renshaw, Andrew A., et al.. (1998). The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer. 83(4). 748–752. 1 indexed citations

11.

Duque, Jose Luis F., Kevin R. Loughlin, Michael P. O’Leary, Sanjaya Kumar, & Jerome P. Richie. (1998). Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology. 52(4). 584–590. 89 indexed citations

12.

D’Amico, Anthony V., Edward J. Holupka, Andrew A. Renshaw, et al.. (1997). Calculated prostate cancer volume: The optimal predictor of actual cancer volume and pathologic stage. Urology. 49(3). 385–391. 36 indexed citations

13.

Heidenreich, Axel, et al.. (1995). A Conservative Approach to Bilateral Testicular Germ Cell Tumors. The Journal of Urology. 153(1). 10–13. 51 indexed citations

14.

Richie, Jerome P., William J. Catàlona, Frederick R. Ahmann, et al.. (1993). Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 42(4). 365–374. 154 indexed citations

15.

Richie, Jerome P.. (1992). INTRAVESICAL CHEMOTHERAPY. Urologic Clinics of North America. 19(3). 521–527. 20 indexed citations

16.

Garnick, Marc B. & Jerome P. Richie. (1983). Urologic cancer : a multidisciplinary perspective. 1 indexed citations

17.

Richie, Jerome P., Robert Blute, & Jerry Waisman. (1980). Immunologic Indicators of Prognosis in Bladder Cancer: The Importance of Cell Surface Antigens. The Journal of Urology. 123(1). 22–24. 63 indexed citations

18.

Richie, Jerome P., et al.. (1978). Glomerulocystic Kidney: Proposed Etiology and Pathogenesis. The Journal of Urology. 119(5). 678–680. 14 indexed citations

19.

Lynch, Donald F., et al.. (1978). Sandwich Therapy in Testis Tumor: Current Experience. The Journal of Urology. 119(5). 612–613. 8 indexed citations

20.

Kaufman, Joseph J. & Jerome P. Richie. (1974). Urethral erosion. Urology. 3(2). 218–220. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact